scispace - formally typeset
T

Troy Stevens

Researcher at University of South Alabama

Publications -  219
Citations -  8794

Troy Stevens is an academic researcher from University of South Alabama. The author has contributed to research in topics: Endothelial stem cell & Endothelium. The author has an hindex of 56, co-authored 207 publications receiving 8097 citations. Previous affiliations of Troy Stevens include Genomics Institute of the Novartis Research Foundation & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Development and Pathology of Pulmonary Hypertension

TL;DR: The Development and Pathology working group was charged with reviewing the present knowledge, gaps in understanding, and areas for further studies in pulmonary vascular biology and pathobiology to provide a blueprint for future research that may significantly impact the present and future understanding of pulmonary hypertension.
Journal ArticleDOI

Host nutritional selenium status as a driving force for influenza virus mutations.

TL;DR: A role for endogenously expressed Trp1 in regulating a Ca2-selective current activated upon Ca2+ store depletion is supported.
Journal ArticleDOI

Mechanisms regulating endothelial cell barrier function

TL;DR: Current concepts of mechanisms regulating endothelial cell barrier function were presented in a symposium at the 2000 Experimental Biology Conference and are reviewed here.
Journal ArticleDOI

The actin cytoskeleton in endothelial cell phenotypes.

TL;DR: The actin cytoskeleton is comprised of three distinct, but inter-related structures, including actin cross-linking of spectrin within the membrane skeleton, the cortical actin rim, and actomyosin-based stress fibers, and discusses cellular signals that control the disposition of actin in different endothelial cell phenotypes.
Journal ArticleDOI

The Cancer Paradigm of Severe Pulmonary Arterial Hypertension

TL;DR: The concept of the endothelial cell as a "quasi-malignant" cell provides a new framework for antiproliferative, antiangiogenic therapy in severe PAH.